Clinically Integrated Network Build

Partnership rejected, partner became competitor → built the growth engine they wouldn’t

THE SITUATION

September 2022. The platform’s distribution-partnership proposal to a national ACO operator gets rejected. The operator follows the rejection with signals of competitive intent: plans to build their own MSO, acquire practices, recruit employed physicians. They had relationships with 240+ practices in the region and were deploying restrictive contracts that locked physicians in for a year or more. Two months later, a national physician enablement company announced a competing CIN with a regional health system targeting the same geography.

In 60 days, the platform went from pursuing partnership to facing two well-capitalized competitors building exactly the commercial entry point it lacked. The clock was running: every month of delay meant more physicians signing exclusive agreements that would lock them out of future affiliation. The platform needed a commercial entry point for the segment of independent physicians who wanted value-based care resources without operational change, and it needed it before the segment got locked up.

WHAT I BUILT

• Commercial positioning: CIN structured as an extension of existing MSO capabilities, differentiating through enhanced FFS rates no ACO could offer. Guaranteed rate lift on day one for joining physicians, anchored by contracts with the largest commercial payer in the state.

• Land-and-expand model: physicians who entered the CIN at low commitment built trust with the platform and became the most qualified pipeline for deeper Practice Affiliation and M&A conversations.

• Clinical integration infrastructure: care protocols, quality measures, data sharing standards. Physician governance across four committees. Antitrust opinion from specialty healthcare counsel to enable joint payer contracting.

• Population health analytics: data platform integrating claims and clinical data through a partnership supporting 70+ EHR systems. PCP scorecards, risk stratification, quality dashboards.

• Board alignment, pipeline development, go-to-market: board presentation secured alignment within 90 days. Six-stage pipeline (mass communications, personalized outreach, target meetings, rate impact analysis, contracting, implementation). Marketing campaign across physician collateral, digital marketing, PR, prospecting webinars.

The CIN was the commercial system that preserved access to the entire independent physician market and created a pipeline that fed every other pathway. Without it, the platform's other affiliation models would compete for an increasingly narrow slice of the market once competitors saturated the VBC-interested segment.

THE RESULT

• Board-approved development plan within 90 days of competitive threat

• Anchor payer contract secured: agreement with the largest commercial payer in the state, delivering the rate structure the CIN was designed around

• Market access preserved: physicians who might have signed exclusive competitor agreements now had an alternative

• 400+ providers across 80+ practice locations now commercially reachable through a pathway that didn’t exist before

• ~28,000 attributed commercial lives in network within two years of board approval

• Land-and-expand pipeline operating: CIN affiliates generating qualified prospects for deeper Practice Affiliation and M&A conversations

• VBC foundation established: infrastructure positioned the platform for a subsequent risk-bearing ACO launch with attributed VBC payments across Commercial and Medicare

Clinical leadership owns ongoing care protocols and quality measures. The payer contracting team manages value-based care arrangements. Population health analytics is embedded in practice support. The CIN operates as a permanent commercial system, both a standalone pathway and a pipeline source for the platform's other affiliation models.

Where is the platform stuck?

Market segment you can’t reach, competitor about to lock it up? Let’s talk.

Start a Conversation